Status and prognostic value of immunological biomarkers of breast cancer

The immune response to cancer serves an important role in disease progression and patient prognosis. For triple-negative breast cancer showing aggressive behavior, immunotherapy has a good efficacy because of the potent immunogenicity of this type of cancer. However, the dominant subtype, luminal hu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology letters 2023-04, Vol.25 (4), p.164, Article 164
Hauptverfasser:	Murazawa, Chisa, Hashimoto, Nozomi, Kuraishi, Kana, Motoyama, Mutsumi, Hashimoto, Shin-Ichiro, Ikeuchi, Mayumi, Norimura, Shoko, Matsunaga, Toru, Teramoto, Koji, Haba, Reiji, Abe, Noriko, Yajima, Toshiki, Kontani, Keiichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antigens Apoptosis B cells Biological markers Biomarkers Biopsy Breast cancer Cancer Cancer therapies Care and treatment Cytotoxicity Immune response Immunology Immunotherapy Lymphocytes Medical prognosis Medical research Monoclonal antibodies Oncology, Experimental Patients Prognosis Surgery T cell receptors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!